▼ SELL
10b5-1 Plan
$ Value
$19K
Shares
3,187
Price
$6
Filed
Dec 15
Insider
Name
Aslan Fred
Title
President and CEO
CIK
0001909362
Roles
Director
Officer
Transaction Details
Transaction Date
2025-12-15
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,209,948
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on July 23, 2024.
Filing Info
Aslan Fred's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-15 | ARTV | A | $0 |
| 2026-02-15 | ARTV | F | $58K |
| 2025-12-15 | ARTV | ▼ | $19K |
| 2025-12-12 | ARTV | A | $0 |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
| 2025-12-12 | ARTV | D | — |
Other Insiders at ARTV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Bush Jennifer
COO, CLO, Secy, Compliance Off
|
— | — | 2026-02-15 |
|
Horan Christopher
Chief Tech Operations Officer
|
— | — | 2026-02-15 |
| Sorg Elaine K. | — | — | 2026-02-18 |
|
Aslan Fred
President and CEO
|
— | — | 2026-02-15 |
|
Raymon Heather
SVP, Research and Development
|
— | — | 2026-02-15 |
|
Banerjee Subhashis
Chief Medical Officer
|
— | — | 2026-02-15 |